Abvc Biopharma (ABVC) EPS (Basic) (2010 - 2026)
Abvc Biopharma's (ABVC) quarterly EPS (Basic) came in at -$0.02 in Q2 2026, up 81.69% on a YoY basis from -$0.01 in Q2 2025, and up 53.16% quarter-over-quarter from -$0.05 in Q1 2026.
Powered by 
Analysis
Abvc Biopharma (ABVC) EPS (Basic) (2010 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has reported EPS (Basic) for 16 consecutive years, with -$0.02 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 81.69% year-over-year to -$0.02; the trailing twelve-month figure through Jun 2026 stood at -$0.27 (down 153.55% YoY), and the FY2025 full-year result was -$0.42, down 192.47% from the prior year.
- EPS (Basic) climbed to -$0.02 in Q2 2026 per ABVC's latest filing, from -$0.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.89 in Q4 2024 and bottomed at -$2.02 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.45 across 5 years, with a median of -$0.23 in 2024.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 211.8% in 2024, then tumbled 495.7% in 2025.
- Over 5 years, EPS (Basic) stood at -$1.54 in 2022, then soared by 48.17% to -$0.8 in 2023, then surged by 211.8% to $0.89 in 2024, then plunged by 116.85% to -$0.15 in 2025, then soared by 83.62% to -$0.02 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.02, -$0.05, and -$0.15 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | -0.02 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02 |
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.15 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | 0.06 |
| Dec 31, 2024 | 0.89 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -0.80 |
| Sep 30, 2023 | -0.82 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.55 |
| Dec 31, 2022 | -1.54 |
| Sep 30, 2022 | -1.14 |
| Jun 30, 2022 | -0.59 |
| Mar 31, 2022 | -2.02 |
| Dec 31, 2021 | -3.17 |
| Sep 30, 2021 | -0.67 |